The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival rate for all cancers combined has reached 70%, up from 49% in the mid-1970s.

Lung cancer remains a leading cause of cancer mortality, with most patients presenting at advanced stages when curative options are limited. Chemotherapy continues to be a central oncologic modality, ...

February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some ...

LUMI-lab, an AI-powered robotic platform trained on 28 million molecules, iteratively optimized lipid nanoparticles and ...

Executive SummaryThe global pharmaceutical drug delivery sector operates as a central pillar within the broader life sciences industry. As treatment protocols shift from conventional dosing toward ...

New therapeutics in development for autoimmune disease and oncologyLead therapeutic BRZ-101 designed to restore immune tolerance in type 1 diabetes, advancing into IND-enabling studiesExpanding ...

Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery. A new SDL system, called LUMI-lab, combines large-scale molecular ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could significantly ...

West Yorkshire health leaders welcome new national cancer plan but warn delivery will be ‘crucial’ for families.

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...

Researchers at UCLA have found a way to supercharge immune cells with a fuel source that tumors can't steal, dramatically ...

Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, ...